C/EBPAmeth status of 99 T-ALLs as a function of their immunophenotype
| . | CD117 . | CD2 . | CD13 . | CD33 . | CD34 . | CD56 . | CD123 . | CD1a . | CD4 . | CD8 . | CD10 . |
|---|---|---|---|---|---|---|---|---|---|---|---|
| C/EBPAmeth | 17* | 53* | 12 | 22 | 29 | 9 | 18 | 49 | 58 | 35 | 38 |
| Non-C/EBPAmeth | 3* | 84* | 18 | 13 | 42 | 14 | 20 | 40 | 51 | 52 | 30 |
| . | CD117 . | CD2 . | CD13 . | CD33 . | CD34 . | CD56 . | CD123 . | CD1a . | CD4 . | CD8 . | CD10 . |
|---|---|---|---|---|---|---|---|---|---|---|---|
| C/EBPAmeth | 17* | 53* | 12 | 22 | 29 | 9 | 18 | 49 | 58 | 35 | 38 |
| Non-C/EBPAmeth | 3* | 84* | 18 | 13 | 42 | 14 | 20 | 40 | 51 | 52 | 30 |
Numbers represent the percentage of positive cases for each antibody tested.
P < .05.